Skip to search boxSkip to navigationSkip to main content

Targeting Mitochondria for the Prevention and Treatment of Nonalcoholic Fatty Liver Disease: Polyphenols as a Non-pharmacological Approach

  • Jaime Zapataf(Author)
    ,
  • Mauricio Castro-Sepulvedab, d, c, a(Author)
    ,
  • Sandra Soto-Alarcone(Author)
    ,
  • Daniela Alvarezf(Author)
    ,
  • Andres Bustamantef(Author)
    ,
  • Guiselle Villarroelf(Author)
Research Output: Contribution to journal Review article Peer-review

Publication Information

Output type

Research Output: Contribution to journal Review article Peer-review

Original language

English

Pages from-to (Number of pages)

Pages 2977-2995 (19 pages)

Journal (Volume, Issue Number)

Current Medicinal Chemistry (Volume 30, Issue 26)

Publication milestones

  • Published - 01/01/2023

Publication status

Published - 01/01/2023

ISSN

0929-8673

External Publication IDs

  • Scopus: 85154572388
  • PubMed: 36214303

Abstract

Scope: Nonalcoholic fatty liver disease (NAFLD) has a high and growing prevalence globally. Mitochondria are fundamental in regulating cell energy homeostasis. Nevertheless, mitochondria control mechanisms can be exceeded in this context of energy overload. Damaged mitochondria worsen NAFLD progression. Diet and lifestyle changes are the main recommendations for NAFLD prevention and treatment. Some polyphenols have improved mitochondrial function in different NAFLD and obesity models. Objective: The study aims to discuss the potential role of polyphenols as a non-pharmacological approach targeting mitochondria to prevent and treat NAFLD, analyzing the influence of polyphenols' chemical structure, limitations and clinical projections. Methods: In vivo and in vitro NAFLD models were considered. Study searches were per-formed using the following keywords: nonalcoholic fatty liver disease, liver steatosis, mi-tochondria, mitochondrial activity, mitochondrial dynamics, mitochondrial dysfunction, mitochondrial morphology, mitochondrial cristae, fusion, fission, polyphenols, flavonoids, anthocyanins, AND/OR bioactive compounds. Conclusion: Polyphenols are a group of diverse bioactive molecules whose bioactive effects are highly determined by their chemical structure. These bioactive compounds could offer an interesting non-pharmacological approach to preventing and treating NAFLD, regulating mitochondrial dynamics and function. Nevertheless, the mitochondria' role in subjects with NAFLD treatment is not fully elucidated. The dosage and bioavailability of these compounds should be addressed when studied.